BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

319 related articles for article (PubMed ID: 5053619)

  • 1. Studies of inhibition of tumour cell DNA synthesis by immune cells in Gross virus induced leukemia.
    Finklestein JZ; Byfield J; Tittle K; Imagawa DT
    Rev Eur Etud Clin Biol; 1972 Mar; 17(3):287-92. PubMed ID: 5053619
    [No Abstract]   [Full Text] [Related]  

  • 2. Comparative immunogenicity of various cellular and cell-free preparations in a leukemia isotransplant system.
    Tennant JR; Kingsley S
    J Natl Cancer Inst; 1971 Nov; 47(5):953-60. PubMed ID: 4330801
    [No Abstract]   [Full Text] [Related]  

  • 3. Suppression of Gross leukemia cell-surface antigens: a kind of antigenic modulation.
    Aoki T; Johnson PA
    J Natl Cancer Inst; 1972 Jul; 49(1):183-92. PubMed ID: 5037434
    [No Abstract]   [Full Text] [Related]  

  • 4. Cell surface expression of cytotoxic T lymphocyte-defined, AKR/Gross leukemia virus-associated tumor antigens by normal AKR.H-2b splenic B cells.
    Green WR
    J Immunol; 1983 Dec; 131(6):3078-84. PubMed ID: 6605998
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immune response to Gross virus-induced lymphoma. I. Kinetics of cytotoxic antibody response.
    Herberman RB; Oren ME
    J Natl Cancer Inst; 1971 Feb; 46(2):391-6. PubMed ID: 5115906
    [No Abstract]   [Full Text] [Related]  

  • 6. [Immunologic studies in virus-induced mouse and rat leukemia. II. Demonstration of a membrane-bound, group-specific leukemia antigen in Graffi and Gross leukemias of the mouse].
    Micheel B; Pasternak G; Bierwolf D
    Acta Biol Med Ger; 1972; 28(1):167-75. PubMed ID: 4114866
    [No Abstract]   [Full Text] [Related]  

  • 7. Protection of C58 mice by normal murine tissues against transplantable leukemia, line Ib.
    Han IH; Johnson AG; Murphy WH
    J Natl Cancer Inst; 1969 May; 42(5):815-24. PubMed ID: 5785010
    [No Abstract]   [Full Text] [Related]  

  • 8. Enzymatic enhancement of cell-mediated cytotoxicity and antibody-dependent cell cytotoxicity.
    Kedar E; Otiz de Landazuri M; Fahey JL
    J Immunol; 1974 Jan; 112(1):26-36. PubMed ID: 4812174
    [No Abstract]   [Full Text] [Related]  

  • 9. Immune inhibition of allogeneic lymphoma cells in the peritoneal cavity of mice.
    Fioretti MC; Libarati M; Bonmassar E; Cudkowicz G
    Cancer Res; 1975 Jan; 35(1):30-6. PubMed ID: 1089042
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Stimulating influence of bacillus Calmette-GuĂ©rin on immunity to polyoma tumors and spontaneous leukemia.
    Lemonde P; Dubreuil R; Guindon A; Lussier G
    J Natl Cancer Inst; 1971 Nov; 47(5):1013-24. PubMed ID: 4330795
    [No Abstract]   [Full Text] [Related]  

  • 11. Suppressed development of cytotoxic lymphoid cells in tumor-immunized mice.
    Martin WJ; Wunderlich JR; Macdonald J
    Isr J Med Sci; 1973 Mar; 9(3):324-31. PubMed ID: 4710040
    [No Abstract]   [Full Text] [Related]  

  • 12. Immune response to Gross virus-induced lymphoma. 3. Characteristics of the cellular immune response.
    De Landazuri MO; Herberman RB
    J Natl Cancer Inst; 1972 Jul; 49(1):147-54. PubMed ID: 5037432
    [No Abstract]   [Full Text] [Related]  

  • 13. Depression of antilymphoma allograft reactivity by tumor-associated factors.
    Bonmassar E; Bonmassar A; Goldin A; Cudkowicz G
    Cancer Res; 1973 May; 33(5):1054-61. PubMed ID: 4703118
    [No Abstract]   [Full Text] [Related]  

  • 14. Tumor cell-related syngeneic skin graft rejection in gross leukemia.
    Mariani T; Maruyama Y; Good RA
    Natl Cancer Inst Monogr; 1972 Dec; 35():309-20. PubMed ID: 4572830
    [No Abstract]   [Full Text] [Related]  

  • 15. [The type specific antigen of Gross leukemia virus in tumors and normal tissues and its identification by immunodiffusion methods].
    Lezhneva OM
    Biull Eksp Biol Med; 1976 Feb; 81(2):217-9. PubMed ID: 819062
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immunologic response of AKR mice in different phases of development of transplanted gross leukemia. II. Comparative investigation of cellular and humoral antibody formation.
    Golubska B; Szalaty H; Stelmachowska A; Skurska Z
    Arch Immunol Ther Exp (Warsz); 1971; 19(3):369-76. PubMed ID: 4938012
    [No Abstract]   [Full Text] [Related]  

  • 17. Tritiated thymidine uptake by in vitro spleen lymphoid cell cultures following stimulation by GC murine leukemia virus.
    Abdel-Wahab KS; Booden T; Albach RA; Wilson DA
    Acta Virol; 1973 Mar; 17(2):105-10. PubMed ID: 4144273
    [No Abstract]   [Full Text] [Related]  

  • 18. Production of migration inhibition factor by spleen cells of normal rats upon culture in vitro with tumor cells and cells expressing endogenous virus.
    Sharma JM; Herberman RB; Djeu JY; Nunn ME
    J Immunol; 1979 Jul; 123(1):222-31. PubMed ID: 221590
    [No Abstract]   [Full Text] [Related]  

  • 19. Receptors for immunoglobulin and complement on mouse leukemias and lymphomas.
    Shevach E; Herberman R; Lieberman R; Frank MM; Green I
    J Immunol; 1972 Feb; 108(2):325-8. PubMed ID: 4340285
    [No Abstract]   [Full Text] [Related]  

  • 20. Modulation of the immune response to transplantation antigens. II. The effects of heterologous antisera on the growth of tumour allografts in mice.
    Zola H
    Clin Exp Immunol; 1974 Mar; 16(3):461-7. PubMed ID: 4468850
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.